Table S9 from A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer
Authors:
- Sheau W. LokSLSheau W. Lok
- James R. WhittleJWJames R. Whittle
- François VaillantFVFrançois Vaillant
- Charis E. TehCTCharis E. Teh
- Louisa L. LoLLLouisa L. Lo
- Antonia N. PolicheniAPAntonia N. Policheni
- Alice R.T. BerginABAlice R.T. Bergin
- Jayesh DesaiJDJayesh Desai
- Sarah FtouniSFSarah Ftouni
- Luke C. GandolfoLGLuke C. Gandolfo
- Danny LiewDLDanny Liew
- He K. LiuHLHe K. Liu
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)